3月5日 - ** 生物技术公司Chimerix CMRX.O股价盘前上涨70.2%至8.42美元
** 两家公司表示，Jazz Pharmaceuticals JAZZ.O将以约9.35亿美元的价格收购 (link) Chimerix，以获得其治疗一种罕见脑瘤的实验性药物
** JAZZ将以每股8.55美元的价格全现金收购Chimerix公司，预计交易将在第二季度完成；与周二的收盘价相比，溢价约72%。
** CMRX 在过去 12 个月中上涨了 320
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.